UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Frontiers in immunology, 2020-01, Vol.10, p.3038-3038

2020

Volltextzugriff (PDF)

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

Nature communications, 2020-11, Vol.11 (1), p.5992-5992, Article 5992

2020

Volltextzugriff (PDF)

Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8929

2024

Volltextzugriff (PDF)

PlGF Immunological Impact during Pregnancy

International journal of molecular sciences, 2020-11, Vol.21 (22), p.8714

2020

Volltextzugriff (PDF)

New Insights into the Potential Role of Chimeric Activating Receptors-Engineered Natural Killer Cells to Fight Cancer

Frontiers in bioscience (Landmark. Print), 2024-08, Vol.29 (8), p.284

2024

Volltextzugriff (PDF)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

Frontiers in immunology, 2020-06, Vol.11, p.1132-1132

2020

Volltextzugriff (PDF)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy

Frontiers in immunology, 2023-06, Vol.14, p.1197053-1197053

2023

Volltextzugriff (PDF)

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy

Frontiers in immunology, 2022-07, Vol.13, p.948297-948297

2022

Volltextzugriff (PDF)

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival

International journal of molecular sciences, 2023-12, Vol.25 (1), p.232

2023

Volltextzugriff (PDF)

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study

Frontiers in immunology, 2022-07, Vol.13, p.886319-886319

2022

Volltextzugriff (PDF)

Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6259

2024

Volltextzugriff (PDF)

Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission

Viruses, 2024-05, Vol.16 (5), p.780

2024

Volltextzugriff (PDF)

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

Journal of translational medicine, 2022-06, Vol.20 (1), p.1-286, Article 286

2022

Volltextzugriff (PDF)

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

PloS one, 2012-10, Vol.7 (10), p.e46928-e46928

2012

Volltextzugriff (PDF)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

Frontiers in immunology, 2021-11, Vol.12, p.778103-778103

2021

Volltextzugriff (PDF)

IFNAR2 Deficiency Causing Dysregulation of NK Cell Functions and Presenting With Hemophagocytic Lymphohistiocytosis

Frontiers in genetics, 2020-09, Vol.11, p.937-937

2020

Volltextzugriff (PDF)

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma

Frontiers in medicine, 2023-02, Vol.10, p.1066021-1066021

2023

Volltextzugriff (PDF)

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

PloS one, 2017-12, Vol.12 (12), p.e0189615-e0189615

2017

Volltextzugriff (PDF)

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001502

2021

Volltextzugriff (PDF)

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors

Oncoimmunology, 2019-02, Vol.8 (2), p.e1542245

2019

Volltextzugriff (PDF)

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma

Oncoimmunology, 2017-06, Vol.6 (6), p.e1316439-e1316439

2017

Volltextzugriff (PDF)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome

Cancers, 2021-08, Vol.13 (17), p.4368

2021

Volltextzugriff (PDF)

Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion

Cell reports (Cambridge), 2017-07, Vol.20 (4), p.846-853

2017

Volltextzugriff (PDF)

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors

Journal of Immunology Research, 2018-01, Vol.2018, p.4972410-10

2018

Volltextzugriff (PDF)

Study of genotoxic and cytotoxic effects induced in human fibroblasts by exposure to pulsed and continuous 1.6 GHz radiofrequency

Frontiers in public health, 2024-07, Vol.12, p.1419525

2024

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Englisch
(50)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies

PlGF Immunological Impact during Pregnancy

New Insights into the Potential Role of Chimeric Activating Receptors-Engineered Natural Killer Cells to Fight Cancer

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study

Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice

Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission

Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

IFNAR2 Deficiency Causing Dysregulation of NK Cell Functions and Presenting With Hemophagocytic Lymphohistiocytosis

Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome

Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors

Study of genotoxic and cytotoxic effects induced in human fibroblasts by exposure to pulsed and continuous 1.6 GHz radiofrequency

Aktive Filter

Suchergebnisse filtern